Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Dominick Angiolillo has recieved honoraria for lectures by Bristol Myers Squibb; Sanofi-Aventis; Eli Lilly Co; Daiichi Sankyo, Inc.; honoraria for advisory board services to Bristol Myers Squibb ...

Eli Lilly on Thursday said its daily obesity pill met the company's goals in the first of several late-stage trials, helping patients with Type 2 diabetes lower their blood sugar and body weight ...